Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20230512058157N1
IRCT20230512058157N1
Recruiting
Phase 3

Comparison of the effect of Follicle Stimulating Hormone(FSH) and Follicle Stimulating Hormone(FSH) along with growth hormone(GH) on ovulation stimulation in Intrauterine insemination (IUI) candidate patients and pregnancy outcomes

Oroumia University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsinfertility.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
infertility.
Sponsor
Oroumia University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Age between 25 and 35 years
  • •Patients with at least one healthy fallopian tube
  • •Normal spermogram
  • •Regular menstrual cycle (26 to 30 days)
  • •FSH level below 20 mIU/ml

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of Recombinant FSH on infertility
IRCT2015061522757N1Tehran university of medical sciences96
Completed
Phase 3
Effect of luteal phase stimulation with follicular phase stimulation in poor ovarian response
IRCT20210405050852N1Avicenna University Jihad Infertility Center Avicenna78
Not yet recruiting
Phase 1
Effects of Follicle-Stimulating Hormone (FSH) on follicular survival in vitrified cryopreservation of human ovarian tissue.
TCTR20170220003The Factory of Medicine, Prince of Songkla University20
Completed
Phase 3
Effect of recombinant HCG administration in infertile women with IVF procedureinfertility.Inability to achieve a pregnancy sterility
IRCT2015012020736N1Vice chancellor for research, Tehran University of medical sciences250
Active, not recruiting
Phase 1
Clinical trial to assess de effect of testosterone in patients with poor ovarian response.Infertility with Poor Ovarian ResponseMedDRA version: 19.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2016-004302-33-ESINSTITUTO DE INVESTIGACIÓN SANITARIA LA FE63